Three Dimensional Fully Convolutional Networks for Segmentation of Optical Coherence Tomography Images in Neurodegenerative Disease

F. Kiaee, H. Fahimi, R. Kafieh, A. U. Brandt, H. Rabbani

Apr 11, 2018 (modified: May 16, 2018) MIDL 2018 Abstract Submission readers: everyone
  • Abstract: Optical coherence tomography (OCT) is an important method for visualization and quantification of intra-retinal layers. OCT-derived measures of retinal layers support investigating the role of afferent visual pathway degeneration in neurode- generative diseases like multiple sclerosis (MS). Therefore, accurate, robust and repeatable segmentation of retinal layers is of interest in such applications. In this paper, a novel 3D fully convolutional deep architecture is proposed for automated segmentation of retinal layers. For this purpose, 3D convolutions explore spatial and inter-frame dimensions to extract features. The proposed network uses a set of convolution and subsampling layers in an alternating fashion to learn a hierarchy of shrinking 3D feature maps (encoder stage). The encoder is then followed by multiple convolution and upsampling blocks enlarging the feature map to the size of original input image for semantic segmentation (decoder stage). The proposed framework was validated on 3D OCT scans of healthy subjects captured by a Topcon 3D OCT device. We contrast the ensemble results with the Deep-Net-2D and Graph-DP methods and observe a significant increase of 6% in the Dice metric for two layers and consistent improvements across the retinal layers. Despite the strategies used for dealing with the class imbalance, contour error values are rather inferior for two layers, but still promising for most of the classes. The results are promising for further application of the approach in neurodegenerative diseases.
  • Author affiliation: Isfahan University of Medical Sciences, Isfahan, IRAN, Charit√© - Universit√§tsmedizin Berlin, Berlin, German
  • Keywords: Optical coherence tomography, fully conventional deep architecture, neurodegenerative diseases
0 Replies